(Q37457570)

English

Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials

scientific article published on 23 April 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

0 references

1 reference

Europe PubMed Central

Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

botulinum toxin type A

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Cidronio Albavera-Hernández

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Jorge M Rodríguez

2

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Alvaro J Idrovo

3

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

publication date

23 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Clinical Rehabilitation

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

394-407

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Neurobiological basis for the use of botulinum toxin in pain therapy

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Pharmacology of therapeutic botulinum toxin preparations

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Safety of botulinum toxin type A: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

AACPDM systematic review of the effectiveness of therapy for children with cerebral palsy after botulinum toxin A injections

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Safety and efficacy of botulinum toxin type A following long-term use.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Better reporting of harms in randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Explaining heterogeneity in meta-analysis: a comparison of methods.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Kinematic aiming task: measuring functional changes in hand and arm movements after botulinum toxin-A injections in children with spastic hemiplegia.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Comparison of the efficacies of botulinum toxin A and Johnstone pressure splints against hip adductor spasticity among patients with cerebral palsy: a randomized trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

An agenda for future debate on concepts of health and disease.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Detection, verification, and quantification of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1177%2F0269215508099860

21 January 2018

Identifiers

10.1177/0269215508099860

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37457570&oldid=1706528344"